发明名称 USE OF ALPHA ADRENERGIC RECEPTOR AGONIST TO REDUCE A DECREASE IN NEUROSENSORY RETINAL FUNCTION FOLLOWING LASER THERAPY FOR CHOROIDAL NEOVASCULARIZATION
摘要 Methods and compositions for the treatment of ocular neovascularization (CNV) and macular degeneration. The invention includes combining laser treatment with administration of a neuroprotectant.
申请公布号 CA2427655(C) 申请公布日期 2011.07.26
申请号 CA20012427655 申请日期 2001.11.01
申请人 ALLERGAN, INC. 发明人 BURKE, JAMES A.;LIN, TON;WHEELER, LARRY A.;DE VRIES, GERALD W.
分类号 A61K41/00;C07D233/50;A61K31/00;A61K31/13;A61K31/4164;A61K31/4168;A61K31/498;A61K31/502;A61K38/18;A61K38/57;A61K45/00;A61K45/06;A61P9/10;A61P9/14;A61P25/02;A61P27/02;A61P39/00;A61P41/00;A61P43/00;C07D403/12 主分类号 A61K41/00
代理机构 代理人
主权项
地址